Literature DB >> 20106865

Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes.

Roger Lee1, Sandy Y Chang, Hung Trinh, Yiping Tu, Andrew C White, Brandon S J Davies, Martin O Bergo, Loren G Fong, William E Lowry, Stephen G Young.   

Abstract

The modification of proteins with farnesyl or geranylgeranyl lipids, a process called protein prenylation, facilitates interactions of proteins with membrane surfaces. Protein prenylation is carried out by a pair of cytosolic enzymes, protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type I (GGTase-I). FTase and GGTase-I have attracted interest as therapeutic targets for both cancer and progeria, but very little information exists on the importance of these enzymes for homeostasis of normal tissues. One study actually suggested that FTase is entirely dispensable. To explore the importance of the protein prenyltransferases for normal tissues, we used conditional knockout alleles for Fntb and Pggt1b (which encode the beta-subunits of FTase and GGTase-I, respectively) and a keratin 14-Cre transgene to create mice lacking FTase or GGTase-I in skin keratinocytes. Keratinocyte-specific Fntb knockout mice were viable but developed severe alopecia. Although hair follicles appeared normal during development, they were morphologically abnormal after birth, and ultrastructural and immunohistochemical studies revealed many apoptotic cells. The interfollicular epidermis of Fntb-deficient mice appeared normal; however, keratinocytes from these mice could not proliferate in culture. As expected, non-farnesylated prelamin A and non-farnesylated DNAJA1 accumulated in Fntb-deficient keratinocytes. Keratinocyte-specific Pggt1b knockout mice survived development but died shortly after birth. Like Fntb-deficient keratinocytes, Pggt1b-deficient keratinocytes did not proliferate in culture. Thus, both FTase and GGTase-I are required for the homeostasis of skin keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106865      PMCID: PMC2846164          DOI: 10.1093/hmg/ddq036

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  56 in total

1.  Using inhibitors of prenylation to block localization and transforming activity.

Authors:  Anastacia C Berzat; Donita C Brady; James J Fiordalisi; Adrienne D Cox
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy.

Authors:  Casey L Moulson; Gloriosa Go; Jennifer M Gardner; Allard C van der Wal; J Henk Sillevis Smitt; Johanna M van Hagen; Jeffrey H Miner
Journal:  J Invest Dermatol       Date:  2005-11       Impact factor: 8.551

3.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

Authors:  Anne P Beigneux; Brandon S J Davies; Peter Gin; Michael M Weinstein; Emily Farber; Xin Qiao; Franklin Peale; Stuart Bunting; Rosemary L Walzem; Jinny S Wong; William S Blaner; Zhi-Ming Ding; Kristan Melford; Nuttaporn Wongsiriroj; Xiao Shu; Fred de Sauvage; Robert O Ryan; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

4.  Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells.

Authors:  R M Castilho; C H Squarize; V Patel; S E Millar; Y Zheng; A Molinolo; J S Gutkind
Journal:  Oncogene       Date:  2007-03-05       Impact factor: 9.867

5.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Margarita Meta; Xin Qiao; David Frost; Joy Bauch; Catherine Coffinier; Sharmila Majumdar; Martin O Bergo; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Prelamin A and lamin A appear to be dispensable in the nuclear lamina.

Authors:  Loren G Fong; Jennifer K Ng; Jan Lammerding; Timothy A Vickers; Margarita Meta; Nathan Coté; Bryant Gavino; Xin Qiao; Sandy Y Chang; Stephanie R Young; Shao H Yang; Colin L Stewart; Richard T Lee; C Frank Bennett; Martin O Bergo; Stephen G Young
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 8.  New approaches to progeria.

Authors:  Mark W Kieran; Leslie Gordon; Monica Kleinman
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

9.  Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Xin Qiao; Loren G Fong; Stephen G Young
Journal:  Biochim Biophys Acta       Date:  2007-11-26

10.  Towards complete sets of farnesylated and geranylgeranylated proteins.

Authors:  Sebastian Maurer-Stroh; Manfred Koranda; Wolfgang Benetka; Georg Schneider; Fernanda L Sirota; Frank Eisenhaber
Journal:  PLoS Comput Biol       Date:  2007-02-23       Impact factor: 4.475

View more
  24 in total

Review 1.  Understanding the roles of nuclear A- and B-type lamins in brain development.

Authors:  Stephen G Young; Hea-Jin Jung; Catherine Coffinier; Loren G Fong
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

2.  Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.

Authors:  Hea-Jin Jung; Catherine Coffinier; Youngshik Choe; Anne P Beigneux; Brandon S J Davies; Shao H Yang; Richard H Barnes; Janet Hong; Tao Sun; Samuel J Pleasure; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24.

Authors:  Sandy Y Chang; Sarah E Hudon-Miller; Shao H Yang; Hea-Jin Jung; John M Lee; Emily Farber; Thangaiah Subramanian; Douglas A Andres; H Peter Spielmann; Christine A Hrycyna; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2012-03-23       Impact factor: 5.922

4.  Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.

Authors:  Catherine Coffinier; Hea-Jin Jung; Ziwei Li; Chika Nobumori; Ui Jeong Yun; Emily A Farber; Brandon S Davies; Michael M Weinstein; Shao H Yang; Jan Lammerding; Javad N Farahani; Laurent A Bentolila; Loren G Fong; Stephen G Young
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

5.  Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases.

Authors:  Shao H Yang; Sandy Y Chang; Yiping Tu; Gregory W Lawson; Martin O Bergo; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2011-10-28       Impact factor: 5.922

6.  An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.

Authors:  Brandon S J Davies; Richard H Barnes; Yiping Tu; Shuxun Ren; Douglas A Andres; H Peter Spielmann; Jan Lammerding; Yibin Wang; Stephen G Young; Loren G Fong
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

7.  An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair.

Authors:  Shao H Yang; Sandy Y Chang; Liya Yin; Yiping Tu; Yan Hu; Yuko Yoshinaga; Pieter J de Jong; Loren G Fong; Stephen G Young
Journal:  Hum Mol Genet       Date:  2011-06-09       Impact factor: 6.150

Review 8.  When lamins go bad: nuclear structure and disease.

Authors:  Katherine H Schreiber; Brian K Kennedy
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

9.  Dynamics of lamin-A processing following precursor accumulation.

Authors:  Qian Liu; Dae In Kim; Janet Syme; Phyllis LuValle; Brian Burke; Kyle J Roux
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors.

Authors:  Stephen A Adam; Veronika Butin-Israeli; Megan M Cleland; Takeshi Shimi; Robert D Goldman
Journal:  Nucleus       Date:  2013-03-01       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.